However, it makes more sense from an IBD perspective wherein one can exploit this unique AhR:E3 ligase complex phenomenon by synthesizing heterobifunctional AhR:E3 ligase chimeras wherein the AhR:E3 ligase can facilitate degradation of a target protein(s) of interest in IBD. Here, AHR is linked to inflammatory bowel disease.